NCT03302091View on ClinicalTrials.gov

A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

August 16, 2018

Study Completion Date

August 16, 2018

Conditions
Renal InsufficiencyHealthy
Interventions
DRUG

BI 1467335

28 day treatment period

Trial Locations (1)

24105

CRS Clinical Research Services Kiel GmbH, Kiel

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03302091 - A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body | Biotech Hunter | Biotech Hunter